Published in Mol Cytogenet on October 25, 2014
Assessment of aneuploidy formation in human blastocysts resulting from donated eggs and the necessity of the embryos for aneuploidy screening. J Assist Reprod Genet (2015) 0.80
Aneuploidy analysis in day 7 human blastocysts produced by in vitro fertilization. Reprod Biol Endocrinol (2016) 0.78
High Aneuploidy Rates Observed in Embryos Derived from Donated Oocytes are Related to Male Aging and High Percentages of Sperm DNA Fragmentation. Clin Med Insights Reprod Health (2015) 0.76
Differences in pregnancy outcomes in donor egg frozen embryo transfer (FET) cycles following preimplantation genetic screening (PGS): a single center retrospective study. J Assist Reprod Genet (2016) 0.75
Genome-wide mapping of in vivo protein-DNA interactions. Science (2007) 64.92
Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA (1992) 2.29
Sperm DNA fragmentation index does not correlate with the sperm or embryo aneuploidy rate in recurrent miscarriage or implantation failure patients. Hum Reprod (2012) 2.12
Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol. Hum Reprod (2010) 2.07
Trends and outcomes for donor oocyte cycles in the United States, 2000-2010. JAMA (2013) 1.90
IVF with preimplantation genetic screening, a promising new treatment with unexpectedly negative health outcomes: the Hippocratic role of Data Monitoring Committees. Hum Reprod (2007) 1.45
Preimplantation genetic screening (PGS) still in search of a clinical application: a systematic review. Reprod Biol Endocrinol (2014) 1.39
New insights into mechanisms behind miscarriage. BMC Med (2013) 1.32
Detection of aneuploidy and chromosomal mosaicism in human embryos during preimplantation sex determination by fluorescent in situ hybridisation, (FISH). Hum Mol Genet (1993) 1.28
No beneficial effect of preimplantation genetic screening in women of advanced maternal age with a high risk for embryonic aneuploidy. Hum Reprod (2008) 1.26
Idiopathic recurrent miscarriage is caused mostly by aneuploid embryos. Fertil Steril (2012) 1.24
Elective single embryo transfer following in vitro fertilization. J Obstet Gynaecol Can (2010) 1.07
Relationship between maternal age and aneuploidy in in vitro fertilization pregnancy loss. Fertil Steril (2004) 1.06
Wide range of chromosome abnormalities in the embryos of young egg donors. Reprod Biomed Online (2006) 1.04
A high degree of aneuploidy in frozen-thawed human preimplantation embryos. Hum Genet (1999) 0.99
Adjusted confidence intervals for a bounded parameter. Behav Genet (2012) 0.97
Application of EU tissue and cell directive screening protocols to anonymous oocyte donors in western Ukraine: data from an Irish IVF programme. J Obstet Gynaecol (2010) 0.97
Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone. Fertil Steril (1998) 0.95
The best donor. Hum Reprod (1999) 0.89
Balancing selected medication costs with total number of daily injections: a preference analysis of GnRH-agonist and antagonist protocols by IVF patients. Reprod Biol Endocrinol (2012) 0.84
Success of donor oocyte in in vitro fertilization-embryo transfer in recipients with and without premature ovarian failure. Fertil Steril (1996) 0.78
Outcomes of donor oocyte cycles in assisted reproduction. JAMA (2013) 0.78
[Contemporary methods of treating age-related infertility]. Ginekol Pol (2005) 0.78
Defective oocytes are not a common cause of unexplained infertility as determined by evaluation of sharing oocytes between infertile donors and recipients. Clin Exp Obstet Gynecol (2013) 0.78
Evaluating the necessity for universal screening of prospective oocyte donors using enhanced genetic and psychological testing. Hum Reprod (2010) 0.77
Oocyte donation--implications for fertility treatment in the nineties. Curr Opin Obstet Gynecol (1994) 0.77